Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. LNTH
LNTH logo

LNTH

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

LNTH News

Lantheus Holdings Reports Strong Q1 2026 Earnings Call Insights

3d agoseekingalpha

Lantheus Holdings Reports Strong Q1 Earnings Growth

3d agoNASDAQ.COM

Lantheus Reports Strong Q1 2026 Results with $377.3M Revenue

3d agoNewsfilter

Lantheus Holdings to Announce Q1 Earnings on May 7

4d agoseekingalpha

Lantheus to Host Q1 2026 Financial Results Call on May 7

Apr 23 2026Newsfilter

Lantheus Holdings Stock Surges Amid FDA Approvals

Apr 19 2026Yahoo Finance

Lantheus LNTH-2501 Review Period Extended by FDA

Mar 18 2026seekingalpha

FDA Extends Review of LNTH-2501 by Three Months

Mar 17 2026stocktwits

Lantheus Holdings Exceeds 2025 Financial Expectations

Mar 09 2026Fool

U.S. Stock Futures Lower, Investors Eye Individual Stocks

Mar 09 2026Benzinga

Lantheus Receives FDA Approval for New Imaging Agent

Mar 07 2026NASDAQ.COM

Lantheus Holdings' PYLARIFY TruVu Injection Receives FDA Approval

Mar 06 2026stocktwits

Lantheus Launches New PSMA PET Imaging Agent PYLARIFY TruVu

Mar 06 2026Newsfilter

Lantheus Holdings Under Investigation for Securities Violations

Mar 02 2026Businesswire

Lantheus Receives FDA Tentative Approval for New Drug

Mar 02 2026Newsfilter

Lantheus Holdings Q4 2025 Earnings Call Insights

Feb 27 2026seekingalpha